Compare TYGO & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TYGO | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.0M | 106.6M |
| IPO Year | 2021 | 2005 |
| Metric | TYGO | LNSR |
|---|---|---|
| Price | $1.04 | $8.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 747.4K | 179.4K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.12 | N/A |
| EPS | 0.01 | ★ 0.61 |
| Revenue | ★ $103,536,000.00 | $58,435,000.00 |
| Revenue This Year | $30.78 | $10.06 |
| Revenue Next Year | $21.68 | $41.48 |
| P/E Ratio | $106.00 | ★ $14.10 |
| Revenue Growth | ★ 91.68 | 9.24 |
| 52 Week Low | $0.93 | $4.95 |
| 52 Week High | $5.33 | $12.94 |
| Indicator | TYGO | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 58.35 |
| Support Level | $1.03 | $5.17 |
| Resistance Level | $1.15 | $12.13 |
| Average True Range (ATR) | 0.05 | 0.35 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 12.50 | 8.65 |
Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.